Filing Details

Accession Number:
0001453814-19-000004
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-02-07 16:24:03
Reporting Period:
2019-02-05
Accepted Time:
2019-02-07 16:24:03
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1453814 Medidata Solutions Inc. MDSO Services-Prepackaged Software (7372) 522319066
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1641826 Rouven Bergmann C/O Medidata Solutions, Inc.
350 Hudson Street, 9Th Floor
New York NY 10014
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-02-05 525 $53.29 79,561 No 4 M Direct
Common Stock Disposition 2019-02-05 525 $75.00 79,036 No 4 S Direct
Common Stock Disposition 2019-02-05 2,512 $75.00 76,524 No 4 S Direct
Common Stock Acquisiton 2019-02-06 9,475 $53.29 85,999 No 4 M Direct
Common Stock Disposition 2019-02-06 9,475 $75.00 76,524 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2019-02-05 525 $0.00 525 $53.29
Common Stock Stock Option (right to buy) Disposition 2019-02-06 9,475 $0.00 9,475 $53.29
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
17,118 2025-05-13 No 4 M Direct
7,643 2025-05-13 No 4 M Direct
Footnotes
  1. The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 26, 2018.
  2. Included are 174 shares which were purchased pursuant to the terms of the Medidata Solutions, Inc. Employee Stock Purchase Plan on December 31, 2018.
  3. Such transaction was executed in multiple trades at prices ranging from $75.00 to $75.01. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  4. The options vested as to 25% of the shares on May 13, 2016 and 1/36th of the remaining options will become exercisable each month thereafter for the next 36 months.